Nkarta Inc • NKTX

Capital at risk.

About Nkarta Inc
Ticker
info
NKTX
Trading on
info
NASDAQ
ISIN
info
US65487U1088
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Paul J. Hastings
Headquarters
info
1150 Veterans Boulevard, South San Francisco, CA, United States, 94080
Employees
info
110
Website
info
nkartatx.com
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Metrics
BasicAdvanced
Market cap
info
$139M
P/E ratio
info
-
EPS
info
-$1.46
Dividend Yield
info
0.00%
Beta
info
0.8
Forward P/E ratio
info
0
EBIDTA
info
$-114M
Ex dividend date
info
-
Price & volume
Market cap
info
$139M
Average daily volume
info
1.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1,000,000
Price to book
info
0.43
Earnings
EPS
info
-$1.46
EPS estimate (current quarter)
info
-$0.35
EPS estimate (next quarter)
info
-$0.35
EBITDA
info
$-114M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.8
52-week High
info
$3.81
52-week Low
info
$1.31
50-day moving average
info
$2.14
200-day moving average
info
$1.98
Short ratio
info
8.87
Short %
info
17.89%
Management effectiveness
ROE (TTM)
info
-26.94%
ROA (TTM)
info
-15.38%
Profit margin
info
0.00%
Gross profit margin
info
$-36.2M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
71M
Float
info
52.5M
Insiders %
info
5.02%
Institutions %
info
86.24%
Analyst Insights & forecasts
info

86% Buy

14% Hold

0% Sell

Based on information from 7 analysts.

Average price target

info
$12.40
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.39
-$0.36
-8.33%
Q3 • 24Missed
-$0.35
-$0.40
12.50%
Q4 • 24Beat
-$0.43
-$0.45
4.44%
Q1 • 25Beat
-$0.31
-$0.35
11.43%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-32M
-∞%
Q1 • 25
$0M
$-23M
-∞%
Q2 • 25
NaN%
-28.16%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$471M
$91.8M
19.51%
Q1 • 25
$448M
$90.6M
20.22%
Q2 • 25
-4.74%
-1.26%
3.65%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-29.6M
$54.3M
$0M
$-30.1M
Q1 • 25
$-18.8M
$19.5M
$0.1M
$-18.9M
Q2 • 25
-36.67%
-64.13%
∞%
-37.30%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Nkarta Inc share?
Collapse

Nkarta Inc shares are currently traded for undefined per share.

How many shares does Nkarta Inc have?
Collapse

Nkarta Inc currently has 71M shares.

Does Nkarta Inc pay dividends?
Collapse

No, Nkarta Inc doesn't pay dividends.

What is Nkarta Inc 52 week high?
Collapse

Nkarta Inc 52 week high is $3.81.

What is Nkarta Inc 52 week low?
Collapse

Nkarta Inc 52 week low is $1.31.

What is the 200-day moving average of Nkarta Inc?
Collapse

Nkarta Inc 200-day moving average is $1.98.

Who is Nkarta Inc CEO?
Collapse

The CEO of Nkarta Inc is Paul J. Hastings.

How many employees Nkarta Inc has?
Collapse

Nkarta Inc has 110 employees.

What is the market cap of Nkarta Inc?
Collapse

The market cap of Nkarta Inc is $139M.

What is the P/E of Nkarta Inc?
Collapse

The current P/E of Nkarta Inc is null.

What is the EPS of Nkarta Inc?
Collapse

The EPS of Nkarta Inc is -$1.46.

What is the PEG Ratio of Nkarta Inc?
Collapse

The PEG Ratio of Nkarta Inc is null.

What do analysts say about Nkarta Inc?
Collapse

According to the analysts Nkarta Inc is considered a buy.